Skip to Main Content
AYTU

Aytu BioPharma, Inc.

2.00 USD
+0.02 (+1.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fundamentals

Fundamental data refers to the information about the company itself, its financial state, sales and revenues, profitability and growth. This is a set of metrics used by financial analysts to gauge the financial health of an organization as well as its future prospects. This page will include information about many of the common fundamental metrics and KPIs used to evaluate and price the value of public corporations in the United States and around the world.

Market-Cap 

23.07M USD

Enterprise Value 

13.79M USD

Price to Earnings Ratio (ttm) 

-1.9

Price to Sales Ratio (ttm) 

0.4

Price to Book Value 

0.7

EV/EBITDA 

-3.1

Revenue 

16.11M USD

Cost of Revenue 

-5.70M USD

Gross Profit 

10.41M USD

Operating Expenses 

-11.19M USD

Net Income 

-15.00K USD

Earnings Per Share, Basic 

0.00 USD

Earnings Per Share, Diluted 

0.00 USD

EBITDA 

344.00K USD

Shares (Basic) 

19,323,098.00

Shares (Diluted) 

19,323,098.00